CClinicalTrials.gg
CompletedNCT06389331Updated Aug 13, 2024

Study on Effects of Defect Closure in Laparoscopic Repair of Direct Inguinal Hernia

An observational study in Hernia, Direct Inguinal Hernia and Seroma Following Procedure, sponsored by B.P. Koirala Institute of Health Sciences. Completed at 1 site in Nepal. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-08-13.

Sponsored by B.P. Koirala Institute of Health Sciences · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
88
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The defect closure was found to have higher pain and less seroma formation at various intervals of time following TEP for moderate-large direct inguinal hernia. Although these findings were statistically insignificant, they may be clinically significant, and further studies with a larger sample size are suggested.

Read the detailed description

Inguinal hernia is a common and widespread condition from which millions of people suffer. Repair of an inguinal hernia is one of the most frequently performed operations in general surgery. Totally extraperitoneal (TEP) and transabdominal preperitoneal (TAPP) repair are the principal techniques in laparoscopic hernia repair. Laparoscopic hernia repair is recommended for bilateral and recurrent inguinal hernias. It has also been recommended for patients with primary unilateral inguinal hernia, contingent on the availability of surgical expertise and resources, due to a lower incidence of post-operative pain and chronic pain.

Seroma formation is a frequent complication of laparoscopic mesh repair of moderate-large direct inguinal hernia defects. While rates of seroma formation have been reported to be as high as 10-30%. Several attempts have been made to reduce the incidence of seroma formation, such as tacking the transversalis fascia (TF) to the ramus of the pubis, closing the direct inguinal hernia defect via the endoloop technique, and filling the potential dead space with fibrin glue. However, there is a potential increase in the risk of infection and also a risk of chronic pubic bone pain from the tack staples or vasculo-nervous injury if fixing the TF to the abdominal wall, which would lead to extra discomfort for the patient. The closure of a direct hernia defect with a barbed suture not only closes the defect superficially but also exterminates the defect cavity; consequently, the incidence of seroma formation has been greatly reduced.

However, there is still controversial evidence regarding the choice of the two procedures in terms of reducing the rate of seroma formation and pain. Thus, it is ambiguous which surgical technique should be considered best to repair an inguinal hernia. In this study, we tried to evaluate the technical aspect of direct defect closure in laparoscopic TEP inguinal hernia repair and its effect on the primary outcomes in terms of seroma formation and pain at different time intervals, along with the secondary outcomes such as operative time, length of postoperative hospital stay, days to resume normal activities, recurrence, and intraoperative complications like injury to the vas, vessel, and visceral injury or peritoneal tear.

02

Conditions studied

  • Hernia
  • Direct Inguinal Hernia
  • Seroma Following Procedure

Keywords

  • TEP
  • Direct Hernia Closure
  • Seroma Formation
  • Pain
03

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients with inguinal hernia presenting to surgery OPD

Inclusion criteria

  • age greater than 18 years
  • uncomplicated direct inguinal hernia (≥M3)

Exclusion criteria

Exclusion Criteria:

  • defect size ≤M2
  • complicated hernia (irreducible, obstructed, or recurrent hernia)
  • patients unfit for general anesthesia
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
88 participants (actual)
Patient registry
No

Groups and cohorts

  • defect closure

    the fascia transversalis (pseudo sac) was pulled and incorporated into closure with a non-absorbable polypropylene barbed monofilament size-0 suture

    Other: closed the defect with barbed suture

  • non closure group

    defect was left open

Interventions

  • Otherclosed the defect with barbed suture

    In direct hernia, content was reduced, and the fascia transversalis (pseudo sac) was pulled and incorporated into closure with a non-absorbable polypropylene barbed monofilament size-0 suture

05

What researchers measure

Primary outcomes

  1. seroma formation in defect closure group

    After closing the defect, there is less seroma formation than in the defect non closure group

    Time frame: till 6 months

06

Study locations

1 site
  • Vijay Pratap Sah
    Malangwa, Madhesh Pradesh, Nepal
07

References and documents

Publications

  • Rutkow IM, Robbins AW. Demographic, classificatory, and socioeconomic aspects of hernia repair in the United States. Surg Clin North Am. 1993 Jun;73(3):413-26. doi: 10.1016/s0039-6109(16)46027-5. PubMed 8497793 ↗
  • McKernan JB, Laws HL. Laparoscopic repair of inguinal hernias using a totally extraperitoneal prosthetic approach. Surg Endosc. 1993 Jan-Feb;7(1):26-8. doi: 10.1007/BF00591232. PubMed 8424228 ↗
  • Usmani F, Wijerathne S, Malik S, Yeo C, Rao J, Lomanto D. Effect of direct defect closure during laparoscopic inguinal hernia repair ("TEP/TAPP plus" technique) on post-operative outcomes. Hernia. 2020 Feb;24(1):167-171. doi: 10.1007/s10029-019-02036-1. Epub 2019 Sep 6. PubMed 31493054 ↗
  • Kockerling F, Bittner R, Adolf D, Fortelny R, Niebuhr H, Mayer F, Schug-Pass C. Seroma following transabdominal preperitoneal patch plasty (TAPP): incidence, risk factors, and preventive measures. Surg Endosc. 2018 May;32(5):2222-2231. doi: 10.1007/s00464-017-5912-3. Epub 2017 Oct 26. PubMed 29075973 ↗

Study documents

  • Protocol and informed consent form · Sep 1, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT06389331
Lead sponsor
B.P. Koirala Institute of Health Sciences
Responsible party
Vijay Pratap Sah (doctor, B.P. Koirala Institute of Health Sciences) — Principal investigator
First posted
Apr 29, 2024
Start date
Sep 1, 2020
Primary completion
Jun 30, 2021
Completion
Aug 31, 2021
Last update
Aug 13, 2024

Study contacts

Rakesh Kumar Gupta, MS
principal investigator · B. P. Koirala institute of health science

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion